Exercise During the Allogeneic Stem Cell Transplantation
1 other identifier
interventional
60
1 country
1
Brief Summary
The study will evaluate the effects of a structured endurance exercise program on the physical performance, the mood and the complications of patients with hematological malignancies undergoing a high-dose chemotherapy followed by an allogeneic peripheral blood stem cell transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started May 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2009
CompletedFirst Posted
Study publicly available on registry
April 20, 2009
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedDecember 23, 2009
December 1, 2009
1.9 years
April 17, 2009
December 21, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2max
At recruitment and after 4 weeks
Secondary Outcomes (3)
Complications
4 weeks
Mood
At recruitment and after 4 weeks
Requirement for blood and platelets transfusions
4 weeks
Study Arms (2)
Supervised exercise
EXPERIMENTALControl group
ACTIVE COMPARATORInterventions
The patients will carry out a daily exercise program consisting of walking on a treadmill for 30 minutes at an intensity of 80% of the maximum heart rate. The patients will be supervised by medical personnel.
The patients will receive instructions about exercise and will have access to a bike ergometer to work out. However, they will not receive daily supervision or participate in a structured exercise program.
Eligibility Criteria
You may qualify if:
- Neoplastic malignancy
- Allogeneic peripheral stem cell transplantation
- Proficiency in German
You may not qualify if:
- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
- Pathological stress-ECG at admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
Berlin, State of Berlin, 12200, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fernando Dimeo, MD
Charite University, Berlin, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 17, 2009
First Posted
April 20, 2009
Study Start
May 1, 2009
Primary Completion
April 1, 2011
Study Completion
August 1, 2011
Last Updated
December 23, 2009
Record last verified: 2009-12